Solve Therapeutics: Funding, Investors & Team (Sep 2026)
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.
Solve Therapeutics has raised $120M across 1 funding round on record, the most recent an undisclosed round of $120M announced in Nov 2025.
That round is above the $42M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Solve Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Solve Therapeutics Funding Rounds
Solve Therapeutics Founders and Leadership Team
Contact details for the Solve Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Solve Therapeutics Funding Compared to Other Biotechnology Startups
Solve Therapeutics' latest round of $120M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Solve Therapeutics in Biotechnology and Belmont
Companies Similar to Solve Therapeutics
Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and…
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal…
Neok Bio is a biotech startup that focuses on bispecific ADCs in cancer therapy.
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
ThirdLaw Molecular pioneers revolutionary Spiroligomer™ molecules for safer, more targeted, effective disease…
Aerska is a biotechnology company that is creating RNA medications to treat, postpone, and prevent brain…
Weike Bio is a gene therapy drug development company.
Twinpig Biolab researches and develops anticancer drugs.
Kunshi Biotechnology is a drug developer with an emphasis on solid tumor cells.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Step Pharma is a biotechnology company.
Solve Therapeutics Funding FAQs
What does Solve Therapeutics do?
Solve Therapeutics is a biopharmaceutical company that develops Antibody Drug Conjugate and Bispecific Therapeutics.
How much funding has Solve Therapeutics raised?
Solve Therapeutics has raised $120M across 1 round on record. The most recent is an undisclosed round of $120M announced in Nov 2025.
When did Solve Therapeutics last raise funding?
Solve Therapeutics' most recent funding round on record is an undisclosed round of $120M, announced in Nov 2025.
Where is Solve Therapeutics headquartered?
Solve Therapeutics is based in Belmont, United States.
How many employees does Solve Therapeutics have?
Solve Therapeutics is in the 11-50 employee band.
How does Solve Therapeutics' funding compare to other Biotechnology startups?
Solve Therapeutics' latest round of $120M is above the $42M median round size for Biotechnology companies on FundedIQ across 20 tracked companies over the last two years.
About FundedIQ's Solve Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Solve Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.